Bjørg Almås

1.8k total citations
38 papers, 1.4k citations indexed

About

Bjørg Almås is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bjørg Almås has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Pathology and Forensic Medicine and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bjørg Almås's work include Vitamin D Research Studies (10 papers), Adrenal Hormones and Disorders (5 papers) and Amino Acid Enzymes and Metabolism (4 papers). Bjørg Almås is often cited by papers focused on Vitamin D Research Studies (10 papers), Adrenal Hormones and Disorders (5 papers) and Amino Acid Enzymes and Metabolism (4 papers). Bjørg Almås collaborates with scholars based in Norway, Denmark and Belgium. Bjørg Almås's co-authors include Rolf Jorde, Yngve Figenschau, Guri Grimnes, Torgeir Flatmark, Jan Haavik, Monika H. E. Christensen, Johan Svartberg, Peter A. Torjesen, Kristian Løvås and Moira Strand Hutchinson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Bjørg Almås

37 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bjørg Almås Norway 21 537 283 276 276 186 38 1.4k
Rona Limor Israel 25 340 0.6× 635 2.2× 446 1.6× 351 1.3× 376 2.0× 62 2.1k
Jean‐Philippe Krieger Switzerland 22 185 0.3× 319 1.1× 272 1.0× 228 0.8× 440 2.4× 56 1.6k
T Lloyd United States 20 307 0.6× 199 0.7× 179 0.6× 109 0.4× 463 2.5× 28 1.5k
Elena Dozio Italy 28 107 0.2× 352 1.2× 498 1.8× 148 0.5× 492 2.6× 107 2.3k
Akihiko Wakatsuki Japan 36 271 0.5× 651 2.3× 520 1.9× 154 0.6× 475 2.6× 150 3.7k
Steinar Hustad Norway 23 126 0.2× 180 0.6× 541 2.0× 176 0.6× 293 1.6× 43 2.4k
Frederick G. Strathmann United States 20 227 0.4× 84 0.3× 251 0.9× 156 0.6× 134 0.7× 60 1.1k
Necat Yılmaz Türkiye 21 140 0.3× 128 0.5× 238 0.9× 88 0.3× 155 0.8× 85 1.2k
H A Ross Netherlands 28 206 0.4× 1.8k 6.3× 398 1.4× 61 0.2× 189 1.0× 73 2.6k
Juha Laakso Finland 27 89 0.2× 182 0.6× 415 1.5× 353 1.3× 704 3.8× 69 2.1k

Countries citing papers authored by Bjørg Almås

Since Specialization
Citations

This map shows the geographic impact of Bjørg Almås's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørg Almås with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørg Almås more than expected).

Fields of papers citing papers by Bjørg Almås

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørg Almås. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørg Almås. The network helps show where Bjørg Almås may publish in the future.

Co-authorship network of co-authors of Bjørg Almås

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørg Almås. A scholar is included among the top collaborators of Bjørg Almås based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørg Almås. Bjørg Almås is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Almås, Bjørg, et al.. (2024). Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane. Breast Cancer Research and Treatment. 206(2). 347–358.
2.
Öberg, Johanna, Rolf Jorde, Bjørg Almås, et al.. (2023). Vitamin D Status During Adolescence and the Impact of Lifestyle Changes: 2 Years’ Follow-up From the Fit Futures Study. The Journal of Clinical Endocrinology & Metabolism. 109(3). e1029–e1039. 2 indexed citations
3.
Averina, Maria, Sandra Huber, Bjørg Almås, et al.. (2023). Early menarche and other endocrine disrupting effects of per- and polyfluoroalkyl substances (PFAS) in adolescents from Northern Norway. The Fit Futures study. Environmental Research. 242. 117703–117703. 21 indexed citations
4.
Ueland, Grethe Åstrøm, Ralf Kellmann, Kristin Viste, et al.. (2021). Bedtime Salivary Cortisol as a Screening Test for Cushing Syndrome in Children. Journal of the Endocrine Society. 5(5). bvab033–bvab033. 8 indexed citations
5.
Kellmann, Ralf, Kristin Viste, Hans Petter Eikesdal, et al.. (2020). An Ultrasensitive Routine LC-MS/MS Method for Estradiol and Estrone in the Clinically Relevant Sub-Picomolar Range. Journal of the Endocrine Society. 4(6). bvaa047–bvaa047. 24 indexed citations
6.
Tangen, Ingvild L., Mari K. Halle, Kristin Viste, et al.. (2019). Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling. Gynecologic Oncology. 156(2). 400–406. 11 indexed citations
7.
Christensen, Monika H. E., et al.. (2014). Estradiol determines the effects of PTH on ERα-dependent transcription in MC3T3-E1 cells. Biochemical and Biophysical Research Communications. 450(1). 360–365. 5 indexed citations
8.
Viste, Kristin, Marianne Aardal Grytaas, Dag Jensen, et al.. (2013). Efficacy of adrenal venous sampling is increased by point of care cortisol analysis. Endocrine Connections. 2(4). 236–242. 18 indexed citations
9.
Methlie, Paal, Steinar Hustad, Bjørg Almås, et al.. (2013). Multisteroid LC–MS/MS assay for glucocorticoids and androgens and its application in Addison's disease. Endocrine Connections. 2(3). 125–136. 77 indexed citations
10.
Kjærgaard, Marie, Knut Waterloo, Catharina Elisabeth Arfwedson Wang, et al.. (2012). Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case—control study and randomised clinical trial. The British Journal of Psychiatry. 201(5). 360–368. 158 indexed citations
11.
Hutchinson, Moira Strand, Yngve Figenschau, Bjørg Almås, Inger Njølstad, & Rolf Jorde. (2011). Serum 25-Hydroxyvitamin D Levels in Subjects with Reduced Glucose Tolerance and Type 2 Diabetes - The Tromsø OGTT-Study. International Journal for Vitamin and Nutrition Research. 81(5). 317–327. 25 indexed citations
12.
Grimnes, Guri, Ragnar M. Joakimsen, Yngve Figenschau, et al.. (2011). The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial. Osteoporosis International. 23(1). 201–211. 66 indexed citations
13.
Christensen, Monika H. E., Simon N. Dankel, Jan Erik Varhaug, et al.. (2011). Primary Hyperparathyroidism Influences the Expression of Inflammatory and Metabolic Genes in Adipose Tissue. PLoS ONE. 6(6). e20481–e20481. 33 indexed citations
14.
Steen, Nils Eiel, Paal Methlie, Steinar Lorentzen, et al.. (2011). Increased Systemic Cortisol Metabolism in Patients With Schizophrenia and Bipolar Disorder. The Journal of Clinical Psychiatry. 72(11). 1515–1521. 42 indexed citations
15.
Løvås, Kristian, Clara Gram Gjesdal, Monika H. E. Christensen, et al.. (2009). Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone. European Journal of Endocrinology. 160(6). 993–1002. 125 indexed citations
16.
Halskau, Øyvind, Ming Ying, Anne Baumann, et al.. (2009). Three-way Interaction between 14-3-3 Proteins, the N-terminal Region of Tyrosine Hydroxylase, and Negatively Charged Membranes. Journal of Biological Chemistry. 284(47). 32758–32769. 37 indexed citations
17.
Emaus, Nina, Clara Gram Gjesdal, Bjørg Almås, et al.. (2009). Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporosis International. 21(10). 1731–1740. 77 indexed citations
18.
Goumon, Yannick, Tommaso Angelone, Françoise Schoentgen, et al.. (2004). The Hippocampal Cholinergic Neurostimulating Peptide, the N-terminal Fragment of the Secreted Phosphatidylethanolamine-binding Protein, Possesses a New Biological Activity on Cardiac Physiology. Journal of Biological Chemistry. 279(13). 13054–13064. 45 indexed citations
19.
Flatmark, Torgeir, Bjørg Almås, & Michael G. Ziegler. (2002). Catecholamine Metabolism: An Update on Key Biosynthetic Enzymes and Vesicular Monoamine Transporters. Annals of the New York Academy of Sciences. 971(1). 69–75. 10 indexed citations
20.
Almås, Bjørg, B. Le Bourdellès, Torgeir Flatmark, Jacques Mallet, & Jan Haavik. (1992). Regulation of recombinant human tyrosine hydroxylase isozymes by catecholamine binding and phosphorylation. European Journal of Biochemistry. 209(1). 249–255. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026